United States · Series A startup

Who invested in PhaseV

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$50Mraised across 1 round since 2025, from 1 source

Latest round
Series A, $50MMay 2025
Investors
2
See who backed them

The rounds

  1. May 2025
    Series A$50M

    Source recorded

Founders and team

From PhaseV's own website: 1 on the team.

  • Gastrointestinal DiseasesPierre Gaudreault, CEO of Alimentiv.

Everyone who backed them

Insight PartnersVC firm1round
Viola Venturesno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about PhaseV

Who invested in PhaseV?

PhaseV's investors include Insight Partners and Viola Ventures.

How much has PhaseV raised?

PhaseV has raised $50M across 1 round since 2025.

When did PhaseV last raise?

PhaseV's most recent round was a Series A of $50M in May 2025.

What was PhaseV's biggest round?

Its most recent round, $50M in May 2025, is also its largest on record.

Who backed PhaseV first?

PhaseV's first round on record, in May 2025, was backed by Insight Partners and Viola Ventures.

What stage is PhaseV at?

PhaseV's latest named round is a Series A, in May 2025.

Where is PhaseV based?

PhaseV is based in the United States.

Companies like PhaseV

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.